Role of immunodeficient animal models in the development of fructose induced NAFLD

Journal of Nutritional Biochemistry

Volumn 25, Issue 2, 2014, Pages 219-226

  Bhattacharjee, Jashdeep ^a   Kumar, Jerald Mahesh ^b   Arindkar, Shailendra ^a   Das, Barun ^a   Pramod, Upadhyay ^a   Juyal, Ramesh C ^a   Majumdar, Subeer S ^a   Nagarajan, Perumal ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

B cells; Fructose; Mouse models; NAFLD; NK cells; T cells

Indexed keywords

ACYL COENZYME A DESATURASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHEMOKINE; FRUCTOSE; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DISEASE COURSE; FLOW CYTOMETRY; FLUID INTAKE; FOOD INTAKE; GLUCOSE TOLERANCE; HISTOPATHOLOGY; IMMUNE DEFICIENCY; IMMUNODETECTION; INSULIN TOLERANCE TEST; LIVER CELL; LIVER HISTOLOGY; MOUSE; NATURAL KILLER CELL; NICK END LABELING; NONALCOHOLIC FATTY LIVER; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ALANINE AMINOTRANSFERASE; ALT; ASPARTATE AMINOTRANSFERASE; AST; B CELLS; CHO; CHOLESTEROL; FRUCTOSE; MCP-1; MONOCYTE ATTRACTING CHEMOKINES-1; MOUSE MODELS; NAFLD; NASH; NATURAL KILLER CELLS; NK; NK CELLS; NON-ALCOHOLIC STEATOHEPATITIS; P53; PBMC; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN 53; SCD-1; SREBP-1C; STEAROYL-COA DESATURASE-1; STEROL REGULATORY ELEMENT-BINDING PROTEIN; T CELLS; TGY; TNFΑ; TRYGLYCERIDES; TUMOR NECROSIS FACTOR ALPHA;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; FATTY LIVER; FLOW CYTOMETRY; FRUCTOSE; GENE EXPRESSION REGULATION; IMMUNOCOMPROMISED HOST; IN SITU NICK-END LABELING; MICE; MICE, NUDE; POLYMERASE CHAIN REACTION;

EID: 84892499269     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.10.010     Document Type: Article

References (23)

1. Nagarajan P., Mahesh Kumar M.J., Venkatesan R., Majundar S.S., Juyal R.C. Genetically modified mouse models for the study of nonalcoholic fatty liver disease. World J Gastroenterol 2012, 18:1141-1153.
2. Spruss A., Kanuri G., Uebel K., Bischoff S.C., Bergheim I. Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice. Antioxidants & Redox Signaling. 2011, 14:2121-2135.
3. Thuy S., Ladurner R., Volynets V., Wagner S., Strahl S., Konigrainer A., et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008, 138:1452-1455.
4. Ouyang X., Cirillo P., Sautin Y., Call M.S., Bruchette J.L., Diehl A.M., et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008, 48:993-999.
5. Bergheim I., Weber S., Vos M., Kramer S., Volynets V., Kaserouni S., et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 2008, 48:983-992.
6. Jurgens H., Haass W., Castaneda T.R., Schurmann A., Koebnick C., Dombrowski F., et al. Consuming fructose-sweetened beverages increases body adiposity in mice. Obes Res 2005, 13:1146-1156.
7. London R.M., George J. Pathogenesis of NASH: animal models. Clin Liver Dis 2007, 11:55-74.
8. Leclercq I.A. Pathogenesis of steatohepatitis: insights from the study of animal models. Acta Gastroenterol Belg 2007, 70:25-31.
9. Tang Y., Bian Z., Zhao L., Liu Y., Liang S., Wang Q., et al. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease. Clinical & Experimental Immunology 2011, 166:281-289.
10. Nishimura S., Manabe I., Nagai R. Adipose tissue inflammation in obesity and metabolic syndrome. Discov Med 2009, 8:55-60.
11. Linton M.F., Major A.S., Fazio S. Proatherogenic role for NK cells revealed. Arterioscler Thromb Vasc Biol 2004, 6:992-994.
12. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
13. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011, 17:610-617.
14. Matarese G., Procaccini C., De Rosa V., Horvath T.L., La Cava A. Regulatory T cells in obesity: the leptin connection. Trends Mol Med 2010, 16:247-256.
15. Lautenbach A., Wrann C.D., Jacobs R., Muller G., Brabant G., Nave H. Altered phenotype of NK cells from obese rats can be normalized by transfer into lean animals. Obesity 2009, 17:1848-1855.
16. Kodela E., Theocharis S., Kouskouti C., Kang K., Sleeman M., Karalis K. A Novel Role for Lymphocytes in Non-Alcoholic Fatty Liver Disease Unmasked by High-Fat Diet-Induced Obesity in RAG1-/- Mice. Endocr Rev 2011, 32(03_MeetingAbstracts):383-385.
17. Schiller N.K., Boisvert W.A., Curtiss L.K. Inflammation in atherosclerosis: lesion formation in LDL receptor-deficient mice with perforin and Lyst (beige) mutations. Arterioscler Thromb Vasc Biol 2002, 22:1341-1346.
18. Shimano H., Shimomura I., Hammer R.E., Herz J., Goldstein J.L., Brown M.S., et al. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J Clin Invest 1997, 100:2115-2124.
19. Matsunami T., Sato Y., Ariga S., Sata T., Shimomura T., Kashimura H., et al. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model. Metabolism 2011, 60:805-814.
20. Westerbacka J., Kolak M., Kiviluoto T., Arkkila P., Siren J., Hamsten A., et al. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 2007, 56:2759-2765.
21. Yahagi N., Shimano H., Matsuzaka T., Sekiya M., Najima Y., Okazaki S., et al. p53 Involvement in the pathogenesis of fatty liver disease. J Biol Chem 2004, 14:20571-20575.
22. O'Shea D., Cawood T.J., O'Farrelly C., Lynch L. Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke. PLoS One 2010, 5:e8660.
23. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009, 15:921-929.